Construction and Application of 3D Microfluidic Liver-On-A-Chip

被引:0
|
作者
Lu, Xueping [1 ]
Zhao, Liang [1 ]
Wang, Xiayan [1 ]
Guo, Guangsheng [1 ]
机构
[1] Beijing Univ Technol, Fac Environm & Life, Ctr Excellence Environm Safety & Biol Effects, Dept Chem, Beijing 100124, Peoples R China
基金
中国国家自然科学基金;
关键词
microfluidic chip; 3D cell culture; organ-on-a-chip; liver-on-a-chip; drug screening; TUMOR SPHEROIDS; DISEASE MODEL; HEPATOCYTES; COCULTURE; CULTURE; TOOL;
D O I
10.7536/PC230116
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
As the largest internal organ in the human body, the liver plays an essential role in the metabolism. The liver or relevant diseases are one of the leading causes of death in the world, with the number of cases surging each year. Therefore, an in-depth understanding of the physiological and biochemical processes and pathological mechanisms of the liver is of great significance for the research, prevention, diagnosis, and treatment of liver-related or metabolism-related diseases. The in vitro liver culture model is an important experimental platform for the study of liver-related biological mechanisms. However, the traditional two-dimensional in vitro cell culture model makes it difficult to reproduce the complex physiological structure and microenvironment of the liver, and lack of disease characteristics. More importantly, the cell structure, gene expression, substance metabolism, and so on in the process of planar culture are significantly different from those in vivo. Microfluidic technology can simulate the physiological structure of liver by designing appropriate micro- structure, providing a microenvironment more like that in vivo by combining with three-dimensional liver tissue culture. Therefore, this paper summarizes the methods and latest progress in constructing 3D liver chips in vitro based on microfluidic technology, including porous membrane culture, hydrogel culture, cell spheroid-based culture, and 3D bioprinting. The applications of 3D cultured liver microchips in remodeling liver physiological structure, exploring mechanism and pathological mechanism, drug screening, and toxicity testing are further summarized. Finally, the potential value and challenges of 3D liver-on-a-chip are discussed.
引用
收藏
页码:1357 / 1368
页数:12
相关论文
共 80 条
  • [1] Porous nanocrystalline silicon membranes as highly permeable and molecularly thin substrates for cell culture
    Agrawal, A. A.
    Nehilla, B. J.
    Reisig, K. V.
    Gaborski, T. R.
    Fang, D. Z.
    Striemer, C. C.
    Fauchet, P. M.
    McGrath, J. L.
    [J]. BIOMATERIALS, 2010, 31 (20) : 5408 - 5417
  • [2] Integrated Array Chip for High-Throughput Screening of Species Differences in Metabolism
    Ai, Xiaoni
    Zhao, Lin
    Lu, Yingyuan
    Hou, Yu
    Lv, Tian
    Jiang, Yong
    Tu, Pengfei
    Guo, Xiaoyu
    [J]. ANALYTICAL CHEMISTRY, 2020, 92 (17) : 11696 - 11704
  • [3] Hepatic organoids for microfluidic drug screening
    Au, Sam H.
    Chamberlain, M. Dean
    Mahesh, Shruthi
    Sefton, Michael V.
    Wheeler, Aaron R.
    [J]. LAB ON A CHIP, 2014, 14 (17) : 3290 - 3299
  • [4] Design and fabrication of a scalable liver-lobule-on-a-chip microphysiological platform
    Banaeiyan, Amin A.
    Theobald, Jannick
    Paukstyte, Jurgita
    Woelfl, Stefan
    Adiels, Caroline B.
    Goksor, Mattias
    [J]. BIOFABRICATION, 2017, 9 (01)
  • [5] Microfluidic organs-on-chips
    Bhatia, Sangeeta N.
    Ingber, Donald E.
    [J]. NATURE BIOTECHNOLOGY, 2014, 32 (08) : 760 - 772
  • [6] A liver-on-a-chip platform with bioprinted hepatic spheroids
    Bhise, Nupura S.
    Manoharan, Vijayan
    Massa, Solange
    Tamayol, Ali
    Ghaderi, Masoumeh
    Miscuglio, Mario
    Lang, Qi
    Zhang, Yu Shrike
    Shin, Su Ryon
    Calzone, Giovanni
    Annabi, Nasim
    Shupe, Thomas D.
    Bishop, Colin E.
    Atala, Anthony
    Dokmeci, Mehmet R.
    Khademhosseini, Ali
    [J]. BIOFABRICATION, 2016, 8 (01)
  • [7] In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed
    Bonanini, Flavio
    Kurek, Dorota
    Previdi, Sara
    Nicolas, Arnaud
    Hendriks, Delilah
    de Ruiter, Sander
    Meyer, Marine
    Cabrer, Maria Clapes
    Dinkelberg, Roelof
    Garcia, Silvia Bonilla
    Kramer, Bart
    Olivier, Thomas
    Hu, Huili
    Lopez-Iglesias, Carmen
    Schavemaker, Frederik
    Walinga, Erik
    Dutta, Devanjali
    Queiroz, Karla
    Domansky, Karel
    Ronden, Bob
    Joore, Jos
    Lanz, Henriette L.
    Peters, Peter J.
    Trietsch, Sebastiaan J.
    Clevers, Hans
    Vulto, Paul
    [J]. ANGIOGENESIS, 2022, 25 (04) : 455 - 470
  • [8] Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model
    Chang, Robert
    Emami, Kamal
    Wu, Honglu
    Sun, Wei
    [J]. BIOFABRICATION, 2010, 2 (04)
  • [9] Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening
    Chen, Yongli
    Gao, Dan
    Liu, Hongxia
    Lin, Shuo
    Jiang, Yuyang
    [J]. ANALYTICA CHIMICA ACTA, 2015, 898 : 85 - 92
  • [10] Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
    Cook, David
    Brown, Dearg
    Alexander, Robert
    March, Ruth
    Morgan, Paul
    Satterthwaite, Gemma
    Pangalos, Menelas N.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (06) : 419 - 431